Target Library by Areas

• Oncology

  Cancer remains one of the most complex and resource-intensive global health challenges. Biocytogen's antibody library delivers high-quality, experimentally validated human antibody sequences to enable rapid proof-of-concept for bispecifics, TCEs, and other next-generation therapies.

  Featured targets: ALPL,CDH6

• Inflammation & Autoimmunity

  Autoimmune diseases affect millions worldwide and continue to rise. Biocytogen's million-scale human antibody library supports rapid screening of multi-mechanism antibodies, accelerating the development of bispecific, trispecific, and TCE therapies.

  Featured targets: ALPL,CDH6

• Neuroscience

  Neurological disorders impact one of the world's largest patient populations. Biocytogen's human antibody library offers broad coverage of neural targets and BBB-shuttle molecules, streamlining development from target validation to molecular design.

  Featured targets: LY6G6D

• Rare Diseases

  Rare diseases are increasingly recognized as a critical area for targeted therapeutic innovation. Biocytogen's human antibody library provides diverse antibodies to accelerate rare disease therapy development. One example is BCG009, an anti-IGF-1R antibody with strong potential in the treatment of thyroid eye disease (TED).

  Featured targets: CDH6,LY6G6D